TPI Expects To Receive GMP By End Of 2014; NVIV Reports FDA Approval To Expedite Enrollment For Pilot Trial
December 17, 2014 at 04:27 AM EST
(TPI) Expects to receive GM, (NVIV) announced approval by the U.S. FDA for an expedited enrollment plan for the company’s ongoing pilot trial of its investigational Neuro-Spinal Scaffold.
